CLEARMIND MEDICINE ANNOUNCES SUCCESSFUL COMPLETION OF SECOND COHORT ENROLLMENT IN ONGOING FDA-APPROVED PHASE I/IIA TRIAL FOR CMND-100

Reuters · 1d ago

Please log in to view news